NIH intends to issue a request for applications (RFA) to solicit projects for the Blueprint Grand Challenge for New Drugs for Diseases and Disorders of the Nervous System. This announcement is affiliated with the NIH Blueprint for Neuroscience Research.
The Blueprint is a framework to enhance cooperative activities among the 16 NIH Institutes, Centers, and Offices that support research on the nervous system.
The goal of this RFA will be to support the development of new small molecule drugs that will transform the treatment of neurological, psychiatric, or other nervous system diseases or conditions. The awards will provide funding to support biological testing of compounds during development; and access to technical, infrastructure, and advisory resources to enable investigators to translate promising lead small molecule compounds into drugs that have completed phase 1 clinical trials.
The purpose of this early notice is to allow potential applicants sufficient time to develop responsive projects and necessary collaborations. The RFA is expected to be published in April 2010 with a receipt date in August 2010.
Potential applicants should contact Dr. Jill Heemskerk, program director, Office of Translational Research, NINDS; telephone: 301-496-1779; email: firstname.lastname@example.org. For more information visit http://grants.nih.gov/grants/guide/notice-files/NOT-NS-10-002.html.